Dynamics of BCMA expression in patients with relapsed/refractory multiple myeloma receiving BCMA-directed CAR-T therapy.
Saved in:
| Title: | Dynamics of BCMA expression in patients with relapsed/refractory multiple myeloma receiving BCMA-directed CAR-T therapy. |
|---|---|
| Authors: | Rana MS; Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University, Stanford, CA, USA., Fernandez-Pol S; Department of Pathology, Stanford University, Stanford, CA, USA., Jensen A; Quantitative Sciences Unit, Stanford School of Medicine, Stanford, CA, USA., Hovanky V; Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University, Stanford, CA, USA., Velayati A; Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University, Stanford, CA, USA., Oak JS; Department of Pathology, Stanford University, Stanford, CA, USA., Silva O; Department of Pathology, Stanford University, Stanford, CA, USA., Ames E; Department of Pathology, Stanford University, Stanford, CA, USA., Muffly LS; Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University, Stanford, CA, USA., Sahaf B; Stanford University School of Medicine, Cancer Correlative Science Unit, Stanford Cancer Institute, Stanford, CA, USA.; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Arai S; Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University, Stanford, CA, USA., Kennedy VE; Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University, Stanford, CA, USA., Bharadwaj S; Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University, Stanford, CA, USA., Iberri DJ; Division of Hematology, Stanford University, Stanford, CA, USA., Liedtke M; Division of Hematology, Stanford University, Stanford, CA, USA., Natkunam Y; Department of Pathology, Stanford University, Stanford, CA, USA., Shiraz P; Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University, Stanford, CA, USA., Weng WK; Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University, Stanford, CA, USA.; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Smith M; Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University, Stanford, CA, USA.; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Frank MJ; Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University, Stanford, CA, USA.; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Mackall CL; Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University, Stanford, CA, USA.; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.; Department of Pediatrics, Bass Center for Childhood Cancer and Blood Disorders, Stanford University School of Medicine, Stanford, CA, USA., Dahiya S; Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University, Stanford, CA, USA.; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Mikkilineni L; Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University, Stanford, CA, USA.; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Miklos DB; Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University, Stanford, CA, USA.; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Hosoya H; Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University, Stanford, CA, USA., Sidana S; Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University, Stanford, CA, USA. Surbhi.Sidana@stanford.edu.; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA. Surbhi.Sidana@stanford.edu. |
| Source: | Blood cancer journal [Blood Cancer J] 2026 Apr 04; Vol. 16 (1). Date of Electronic Publication: 2026 Apr 04. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
